CAS ID: | 50-35-1 |
Molecular Formula: | C13H10N2O4 |
Molecular Weight: | 258.2 g/mol |
Monoisotopic Mass: | 258.0641 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | THALIDOMIDE | TALIDEX | K-17 | THALIDOMIDE | THALOMID |
Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
ClinicalTrial ID | NCT00162760 | Disease | Idiopathic pulmonary fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | September 13, 2005 | Last Verified | June 22, 2010 |
Sponsor | Johns Hopkins University |
Trial Record 2
ClinicalTrial ID | NCT00600028 | Disease | Idiopathic pulmonary fibrosis |
Phase | Phase 3 | Status | Completed |
First Received | January 24, 2008 | Last Verified | May 15, 2017 |
Sponsor | Johns Hopkins University |